ANTI-INFLIXIMAB ANTIBODIES AS A MARKER OF DRUG SURVIVAL AND TAPERING IN ANKYLOSING SPONDYLITIS PATIENTS: 12 YEARS FOLLOW-UP

ARTHRITIS & RHEUMATOLOGY(2023)

引用 0|浏览1
暂无评分
关键词
Ankylosing Spondylitis
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要